Skip to Content

Bio-Genex Laboratories Inc BGNX

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Bio-Genex Laboratories Inc is a United States based company engaged in the business of designing, developing and commercializing molecular pathology systems for cancer diagnosis, prognosis, precession medicine and life science research. Its products include Xmatrx systems, i6000 systems, i500 Plus, EZ-Retriever, IHC primary antibodies, microRNA probes, special stains, and IHC/ISH detection kits, among others. The product areas in which the company focuses on are multiple fully automated molecular pathology workstations, Immunohistochemistry, In-situ hybridization, Fluorescence in-situ hybridization, Multiplex stains, In-situ PCR, and MicroRNA and HPV probe system. The organization has a business presence all around the globe.

Contact
49026 Milmont Drive
Fremont, CA, 94538
T +1 510 824-1400
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Dec 31, 2008
Stock Type
Employees